Objective: In the metabolic syndrome (MetS), increased fat storage in 'nonadipose' tissues such as skeletal muscle may be related to insulin resistance ('lipid overflow' hypothesis). The objective of this study was to examine the effects of dietary fat modification on the capacity of skeletal muscle to handle dietary and endogenous fatty acids (FAs). Subjects and Methods: In total, 29 men with the MetS were randomly assigned to one of four diets for 12 weeks: a high-fat saturated fat diet (HSFA, n ¼ 6), a high-fat monounsaturated fat diet (HMUFA, n ¼ 7) and two low-fat high-complex carbohydrate diets supplemented with (LFHCCnÀ3, n ¼ 8) or without (LFHCC, n ¼ 8) 1.24 g per day docosahexaenoic and eicosapentaenoic acid. Fasting and postprandial skeletal muscle FA handling was examined by measuring arteriovenous concentration differences across the forearm muscle.
Introduction
The metabolic syndrome (MetS) represents a clustering of risk factors for the development of type 2 diabetes and cardiovascular disease. 1 Skeletal muscle and adipose tissue are important organs in regulating fatty acid (FA) metabolism and disturbances in their function may lead to insulin resistance (IR) and dyslipidemia as seen in the MetS. 2, 3 When the capacity of adipose tissue to store lipid becomes insufficient, most often associated with chronic excessive energy intake (in particular by means of dietary fat) and/or a sedentary lifestyle, this may lead to an increased supply of triacylglycerol (TAG) and free fatty acids (FFAs) to 'nonadipose' tissues, such as skeletal muscle and liver ('lipid overflow' hypothesis). 3 Consequently, if the uptake of FA exceeds the capacity or the need to oxidize fat in skeletal muscle or liver, the FAs are stored, leading to ectopic fat accumulation. Moreover, it has been reported that the capacity to oxidize fat in IR skeletal muscle is impaired. 4, 5 Ectopic fat disposition, in particular the accumulation of lipid metabolites, may reduce insulin action in skeletal muscle by interfering with insulin signaling and/or by inducing inflammatory pathways. [6] [7] [8] Dietary intervention, aimed at reducing the intake of saturated fat, may improve lipid metabolism and insulin action in the MetS, possibly through effects on lipid overflow and skeletal muscle FA handling. It remains an issue of debate whether saturated fat should be replaced by carbohydrates or unsaturated fat, and so far, little information is available on the relation between dietary fat quantity and quality and skeletal muscle FA handling in vivo. Polyunsaturated fatty acids (PUFAs) may chronically stimulate adipocyte differentiation, 9 thereby increasing lipid storage in adipose tissue and reducing lipid overflow toward muscle. In addition, there are indications from both human muscle cell lines and rodents that saturated fatty acids (SFAs) accumulate preferentially as diacylglycerol, thereby inhibiting insulin signaling, whereas unsaturated FA are more readily converted into TAG. 10, 11 Also, replacing SFA by unsaturated FA may favor fat oxidation above storage, 10 and a 3-day high-carbohydrate diet has been shown to induce changes in partitioning of FA in healthy subjects, leading to increased fat deposition in liver and muscle. 12 Recently, a dual stable isotope study was validated to study FA handling in adipose tissue and skeletal muscle in detail, 13 which offers, in combination with tissue balance techniques, unique possibilities for studying the contribution of dietary vs endogenous FA to lipid overflow and storage in skeletal muscle. Using this technique, the aim of this study was to examine the effects of a 12-week dietary intervention with isoenergetic diets varying in both fat quality and quantity on fasting and postprandial skeletal muscle FA handling in a subcohort of men with the MetS within the LIPGENE human dietary intervention study.
Methods
The LIPGENE human dietary intervention study was a randomized, controlled trial, carried out at eight different centers across Europe as part of the EU Sixth Framework project LIPGENE. In total, 486 volunteers with the MetS at the age of 35-70 years and body mass index between 20 and 40 kg m À2 were included in this study and randomly assigned to receive one of four dietary intervention treatments for a 12-week period. 14 This study was performed in a subcohort of men in the Netherlands within this study. All subjects were informed about the nature of the study and written informed consent was attained before study participation. The study protocol was approved by the local research ethics committees at each of the eight intervention centers.
Subjects
In total, 29 men with the MetS were included in this study. The definition of the MetS was based on the NCEP ATP III report, 15 with subjects meeting at least three of the following Dietary intervention study Subjects were randomly assigned to one of four intervention diets:
(1) High-fat (38% energy (E%)) SFA-rich diet (16E% SFA, 12E% monounsaturated fatty acids (MUFA), 6E% PUFA) (HSFA) (2) High-fat (38E%) MUFA-rich diet (8E% SFA, 20E% MUFA, 6E% PUFA) (HMUFA) (3) Isoenergetic low-fat (28E%), high-complex carbohydrate diet (8E% SFA, 11E% MUFA, 6E% PUFA), with a control high-oleic acid sunflower-seed oil capsule (1 g per day) (LFHCC) (4) Isoenergetic low-fat (28E%), high-complex carbohydrate diet (8E% SFA, 11E% MUFA, 6E% PUFA), with a long-chain (LC) nÀ3 PUFA supplement (1.24 g per day of eicosapentaenoic and docosahexaenoic acid, ratio 1.4:1) (LFHCCnÀ3)
A range of fat-modified food products (margarines, cooking and baking fats, mayonnaise, dressing and biscuits) were produced by Unilever Food & Health Research Institute (Unilever R&D, Vlaardingen, the Netherlands) and provided to subjects with specific dietetic counseling. Carbohydrate exchanges were used to ensure that all diets were isoenergetic and one exchange of carbohydrates was considered as 35 g of complex carbohydrates (that is, one potato, slice of brown bread, handful of rice). Loders-Croklaan (Wormerveer, the Netherlands) supplied the study capsules used in diet LFHCC and LFHCCnÀ3.
All subjects completed 3-day weighed food diaries at baseline, week 6, and week 12, and center-specific dietary analysis programs were used to analyze the food diaries. A detailed description of the food exchange model and assessment of compliance was published elsewhere.
14 Subjects had to remain weight stable (changes were allowed within the range of 2 kg) during the intervention period and were asked to maintain their normal pattern of physical activity, alcohol consumption and smoking.
Experimental design
Pre-and post-intervention, subjects came to the university after an overnight fast on two different occasions. On one Postprandial study Subjects came to the university after an overnight fast and were asked to refrain from drinking alcohol and to perform no strenuous exercise 24 h before the study day. In addition, they were asked to avoid food products naturally enriched with [ 13 C] for 7 days before the study day. Skeletal muscle metabolism was studied in the forearm muscle, using arteriovenous concentration differences corrected for blood flow. Three catheters were inserted before the start of the experiment. In one arm, a catheter was placed in the radial artery of the forearm to sample arterial blood, and another catheter was placed in an antecubital vein for the infusion of [ Energy expenditure, whole-body substrate utilization and respiratory quotient were measured using an open-circuit ventilated hood system during fasting and at t30, t60, t90, t120, t180 and t240 after meal ingestion.
Biochemical analyses
Blood was collected in tubes containing ethylenediaminetetraacetic acid, centrifuged (1000 g, 10 min, 4 1C), and plasma was immediately frozen in liquid nitrogen and stored at À80 1C until analysis. Plasma FFA (Wako NEFA C kit, Sopar Biochemicals, Koekelberg, Belgium) and 3-hydroxybutyrate (Sigma, St Louis, MO, USA) were analyzed using standard enzymatic techniques automated on a Cobas Fara centrifugal spectrophotometer (Roche Diagnostica, Basel, Switzerland). Plasma TAG (Sigma), glycerol (EnzyPlus; Diffchamb, Västa Frölunda, Sweden), glucose and lactate (ABX Diagnostics, Montpellier, France) were analyzed enzymatically on a Cobas Mira automated spectrophotometer (Roche Diagnostica). Plasma insulin was measured with a double antibody radioimmunoassay (Linco Research Inc., St Charles, MO, USA). Plasma total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were determined with an ILab 600 clinical chemical analyzer (Instrumentation Laboratory, Warrington, UK), using enzymatic colorimetric kits. Hematocrite was determined in heparinized blood using a microcapillary system.
To determine the tracer enrichment in plasma FFA and TAG, we extracted total lipids from the plasma using chloroform/methanol 2:1. The FFA and TAG fractions were separated by thin-layer chromatography and derivatized to their methyl esters for the analysis of plasma palmitate. Plasma fractions were analyzed for the 13 C/ 12 C ratio in a gas chromatography continuous-flow isotope ratio-mass spectrometer (Finnigan MAT-252 GC-IRMS, Bremen, Germany) and for enrichment of [ ) were analyzed on an analytical GC with ion flame detection using heptadecanoic acid as internal standard.
Calculations
Insulin sensitivity (S I ) was determined using the MINMOD Millennium program (version 6.02; R Bergman, Los Angeles, CA, USA). 17 The homeostasis model assessment for insulin resistance (HOMA IR ) was calculated according to Matthews For comparing postprandial responses, the incremental area under the curve (iAUC) of metabolites and substrate fluxes was calculated using the trapezium rule. The iAUC was calculated for the 'total' (0-4 h after meal ingestion), 'early' (0-2 h) and 'mid' (2-4 h) postprandial phase.
Statistical methods
Statistical analyses were performed using SPSS 15.0 for Windows (SPSS Inc., Chicago, IL, USA). All data are presented as mean±standard error of the mean (s.e.m.). One-way analysis of variance (ANOVA) was used to test for differences between dietary intervention groups pre-intervention. Repeated-measures ANOVA was applied to test for differences in changes between groups pre-and post-intervention, with time as within-subjects factor and diet as between-subjects factor. When a significant diet by time interaction was observed, post-hoc testing was performed on change data (post-pre) using unpaired t-tests comparing each diet (HMUFA, LFHCC and LFHCCnÀ3) to the HSFA diet. Statistical significance was set at Po0.05.
Results
In total, 29 men with the MetS completed pre-and postintervention measurements (HSFA, n ¼ 6; HMUFA, n ¼ 7; LFHHC, n ¼ 8 and LFHCCnÀ3, n ¼ 8). Subject characteristics were comparable between groups pre-intervention, except for body weight (P ¼ 0.019, one-way ANOVA), which was higher in the HMUFA group as compared to the HSFA group (P ¼ 0.007, post hoc) ( Table 1) . By definition, subjects primarily had a large waist circumference, elevated blood pressure and low fasting plasma high-density lipoprotein cholesterol concentrations, whereas mean fasting plasma glucose and TAG concentrations were only slightly elevated. Dietary intervention did not result in significant changes in the characteristics of the MetS and did not change insulin sensitivity (S I ) and insulin resistance (HOMA IR ) in this subcohort of the LIPGENE study (Table 1) .
Dietary macronutrient intake
Dietary analyses in the total LIPGENE cohort showed that the food-exchange model was successfully implemented in 
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AMJ van Hees et al the study overall. 14 Also in this subcohort of the LIPGENE study, dietary fat intake (E%) during intervention was significantly higher in the HSFA and HMUFA diets than in both LFHCC diets, which was achieved by higher intakes of carbohydrates (E%) in the LFHCC diets as compared to the high-fat diets. Furthermore, subjects on the HSFA diet had significantly higher intakes of SFA (E%) when compared to the other diets, whereas subjects on the HMUFA diet had significantly higher intakes of MUFA (E%) than the other diets. Subjects on the LFHCC and LFHCCnÀ3 diet reported X85% compliance to the placebo and LC nÀ3 PUFA capsules.
14 Arterial metabolites, forearm muscle metabolism and forearm blood flow Arterial plasma glucose (Figure 1 ), insulin (Figure 2 ), lactate, free glycerol and 3-hydroxybutyrate concentrations during fasting and after meal ingestion were comparable between groups pre-and post-intervention. In addition, no significant changes in fluxes of glucose, lactate, free glycerol and 3-hydroxybutyrate across the forearm muscle were observed between diets (data not shown). Pre-intervention forearm blood flow was significantly higher in subjects on the HSFA diet as compared to the other diets during fasting (P ¼ 0.005, one-way ANOVA) and postprandially after meal ingestion (P ¼ 0.002, one-way ANOVA) ( Table 2) . No pronounced diet-induced changes were observed after intervention.
Whole-body and forearm muscle FFA metabolism Whole-body FFA metabolism. Fasting arterial FFA concentrations were similar between groups pre-intervention and did not change differently after dietary intervention ( Figure 3 , Table 2 ). Postprandially, arterial FFA concentrations decreased during the first 2 h and returned to fasting values after 4 h at all times ( Figure 3 ). In subjects on the HSFA diet, Skeletal muscle fatty acid handling in the MetS AMJ van Hees et al however, we observed a steeper increase in arterial FFA concentrations in the mid-postprandial period (iAUC 2À4 h ) after dietary intervention (P ¼ 0.020, diet by time interaction), as compared to the HMUFA (P ¼ 0.046) and LFHCC diet (P ¼ 0.030). Consistent with these findings, the Ra FFA in the circulation decreased after meal ingestion at all times, which is indicative of suppression of whole-body lipolysis (Table 2) . After dietary intervention, a tendency toward a higher increase in the Ra FFA in the mid-postprandial period (iAUC 2À4 h , P ¼ 0.063 for diet by time interaction) was observed on the HSFA diet as compared to the LFHCC diet (change in iAUC, respectively, 0.66±0.31 vs À0.28± 0.20 mmol kg À1 min
À1
, P ¼ 0.020). Forearm muscle FFA metabolism. The net flux of plasma FFA across forearm muscle (arteriovenous concentration difference multiplied by FPF) was negative during the first 2 h of the postprandial period in all intervention groups, indicating a net release of FFA by forearm muscle, without significant differences between the groups pre-and post-intervention ( The postprandial TAG response (iAUC, 0-4 h) was significantly changed after dietary intervention (P ¼ 0.026, diet by time interaction) (Table 3) , with a decreased postprandial TAG response on the LFHCCnÀ3 diet as compared to the HSFA diet (change in iAUC, respectively, À139 ± 67 vs 167 ± 70 mmol l À1 min
, P ¼ 0.009, post hoc). In addition, the postprandial [ Table 3 ). The net flux of plasma TAG across forearm muscle (arteriovenous concentration difference multiplied by FPF) was not different between groups pre-and post-intervention. During fasting, the clearance of plasma TAG across forearm muscle (fractional extraction of TAG multiplied by FPF) was significantly changed after dietary intervention (P ¼ 0.023, diet by time interaction), with a decreased clearance of TAG on the HSFA diet as compared to the LFHCC (P ¼ 0.022) and LFHCCnÀ3 diet (P ¼ 0.017). In the postprandial state, no differences were observed between diets in forearm muscle TAG clearance (Table 3) .
Altogether, albeit postprandial arterial unlabeled and [ 13 C]-labeled TAG concentrations were lower in subjects on the LFHCCnÀ3 diet as compared to the HSFA diet, no significant changes in postprandial net uptake, extraction or clearance of both unlabeled and labeled TAG across forearm muscle were observed.
Energy expenditure and whole-body substrate metabolism Whole-body energy expenditure, respiratory quotient, carbohydrate oxidation and fat oxidation during fasting and after meal ingestion were comparable between groups pre-and post-intervention (data not shown). Abbreviations: FFA, free fatty acid; HMUFA, high-fat monounsaturated fat diet; HSFA, high-fat saturated fat diet; LFHCC, low-fat high-complex carbohydrate. Values are mean ± s.e.m. Postprandial data are expressed as iAUC per min and based on the total postprandial period (0-4 h after meal ingestion) unless otherwise stated.
a For arterial FFA concentrations:
.05 for differences between groups pre-intervention, one-way ANOVA. 
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Discussion
This study shows that isoenergetic modulation of dietary fat quality and quantity did not affect postprandial skeletal muscle FA handling and insulin sensitivity in men with the MetS, whereas in the fasting state clearance of plasma TAG across forearm muscle was decreased on the HSFA diet as compared to the LFHCC and LFHCCnÀ3 diet. Postprandial arterial TAG concentrations, derived from dietary fat, were lower after the LFHCCnÀ3 diet as compared to the HSFA diet.
Skeletal muscle fatty acid handling
Lifestyle intervention can improve metabolic flexibility of skeletal muscle, which refers to the ability of the muscle to increase fat oxidation upon increased FA availability and to switch between fat and carbohydrate oxidation under different conditions, such as the fasting-to-fed state. 20, 21 These interventions were mainly aimed at weight loss and/or chronic exercise training, and little information is available on the effects of dietary fat composition on in vivo skeletal muscle FA handling and metabolic flexibility. 21 A specific objective of the LIPGENE study was to define the effect of isoenergetic modification of dietary fat quality and quantity. To our knowledge, this is the first time that skeletal muscle FA handling was studied in vivo before and after a longer-term dietary fat intervention in weight-stable men with the MetS. Studies in rodents show that the quality of FA (SFA, MUFA, nÀ3 and nÀ6 PUFA) can influence insulin action due to effects on FA incorporation into different lipid fractions, altered substrate oxidation and/or modulation of phospholipids in the muscle membrane. 11, [22] [23] [24] Also, short-term highfat diets have been linked to increased intramyocellular lipid content and skeletal muscle IR in both rodent and human studies, 22, [25] [26] [27] which could be ascribed to increased FA uptake upon increased FA availability. 25 In this study, a 12-week intervention on dietary fat quality and quantity did not affect the postprandial uptake of endogenous and dietary FA by forearm muscle and did not have an effect on fat oxidation. Skeletal muscle fatty acid handling in the MetS AMJ van Hees et al
During fasting conditions, clearance of plasma TAG across forearm muscle was decreased on the HSFA diet as compared to both LFHCC diets, indicating decreased efficiency of TAG removal on the HSFA diet. At the same time, fasting fat oxidation was not changed on the diets, indicating no effects on FA partitioning between oxidation and storage. This seems to be in contrast with a recent study in healthy subjects showing that a 3-day high-carbohydrate diet, when compared to a high-fat diet, leads to repartitioning of dietary FA from oxidation toward storage in both muscle and liver, together with lower fasting and postprandial clearance of TAG across muscle. 12 This could be related to the duration of the diet (short term vs 12 week). It can be speculated that forearm muscle FA uptake may have been increased during the first week(s) of dietary intervention, such as described in short-term studies, and that an increased intramyocellular lipid content led to a decreased FFA concentration gradient across the muscle membrane, thereby decreasing FA uptake in the longer term. 21 Another possibility is the fact that we carefully designed the diets to be isoenergetic. A chronic positive energy balance, mainly due to excessive fat intake, would most probably have a larger impact on nutritional partitioning, and in particular lipid storage. 21 Taken together, our data suggest that isoenergetic variation in dietary fat quantity and quality did not affect forearm muscle FA metabolism and insulin sensitivity, indicating that man may be well capable of adapting to longer-term changes in the diet. Also, in the total LIPGENE human dietary intervention study, powered to study the effects of dietary fat quantity and quality on insulin sensitivity in 480 men and women, no effects on insulin sensitivity were observed. 28 
Circulating lipids
On the HSFA diet a slightly more rapid increase in arterial FFA concentrations and Ra FFA were observed in the midpostprandial period, which may be indicative of a reduced postprandial suppression of adipose tissue lipolysis and subsequent lipid overflow into the circulation on the HSFA diet. However, this was not accompanied by any change in FA uptake across forearm muscle. Skeletal muscle fatty acid handling in the MetS AMJ van Hees et al Table 3 Fasting and postprandial TAG metabolism before and after a 12-week dietary intervention study This study showed that an LFHCCnÀ3 diet decreased postprandial circulating TAG concentrations as compared to an isoenergetic HSFA diet. This lipid-lowering effect of LC nÀ3 PUFA is well documented, but underlying mechanisms are still unclear. It has been shown in humans that omega-3 supplementation accelerates the clearance of chylomicron-TAG, thereby lowering postprandial TAG concentrations, 29 whereas on the other hand studies report that fish oil may enhance postprandial hepatic fat oxidation and/or decrease VLDL-TAG output by the liver. 30 The unique dual stable isotope technique in combination with measurements of arteriovenous concentrations differences across forearm muscle that was applied in this study enabled us to study the direction of the different fluxes in circulating lipid fractions in the postprandial period in more detail. We were able to show that the attenuated postprandial TAG response on the LFHCCnÀ3 diet could be (partly) explained by lower meal-derived FA in the circulation, mainly in the midpostprandial period (2-4 h), whereas no difference or even an increase in endogenous-derived circulating VLDL-TAG was observed. This suggests that LC nÀ3 PUFA, when supplemented to a low-fat diet, mainly exert their TAG-lowering effect through enhanced clearance of chylomicron-TAG from the circulation and/or through an attenuated or decelerated chylomicron-TAG output by the intestine, but not through decreased hepatic VLDL-TAG output. These data are in line with previous reported findings that dietary supplementation with LC nÀ3 PUFA increases LPL activity in healthy subjects and hypertriacylglycerolemic patients, 29, 31, 32 and that chylomicrons are the preferred substrate for LPL-mediated hydrolysis, both across adipose tissue and skeletal muscle. 13 Because we observed no differences in postprandial TAG uptake across forearm muscle, increased LPL activity in the capillary bed of adipose tissue seems to be a plausible explanation for the lower arterial TAG concentrations after the LFHCCnÀ3 diet. Several methodological issues remain to be addressed. First, the sample size in this study was relatively small for detecting changes in skeletal muscle FA handling as a result of a chronic dietary intervention. Therefore, we cannot exclude that small differences in forearm muscle metabolism were present after dietary intervention, which could not be detected in our groups. Second, a small negative flux of FFA across the forearm muscle was observed during fasting in most dietary intervention groups, which was not significantly different from zero. FFA fluxes across the forearm muscle often fluctuate around zero, as there is both release and uptake of FFA across the muscle at the same time. 4, 33, 34 Although we cannot exclude a small contribution from subcutaneous and perivascular adipose tissue, these FAs most likely mainly derive from lipolysis of intramyocellular lipids or adipocytes between muscle bundles (extramyocellular), or from impaired uptake of TAG-derived FA (that is, 'spillover') across skeletal muscle.
Overall, we showed that the range of dietary fat intake (both quantity and quality) under conditions of isoenergetic exchange in this study was insufficient to affect forearm muscle FA handling and whole-body insulin sensitivity in the longer term, although fasting TAG clearance seems to be reduced on the HSFA diet. Decreased postprandial plasma TAG concentrations on an LFHCCnÀ3 diet, possibly explained by an increased capacity of adipose tissue to take up (dietary) FA by increased LPL activity, may in the longer term have beneficial effects on skeletal muscle insulin sensitivity by reducing lipid overflow to the skeletal muscle.
Conflict of interest
The authors declare no conflict of interest.
